NEWS CENTER

Keyuan Pharmaceutical participates in drafting the "Guidelines for Digital Transformation in Pharmaceutical Companies," helping pharmaceutical enterprises achieve digital transformation and upgrading!

Publish Time:

2024-11-05

"The Guide for Digital Transformation in Pharmaceutical Companies" covers multiple aspects, including transformation planning, resource support, operational implementation, evaluation and inspection, as well as continuous improvement. It aims to help enterprises establish a scientific digital transformation framework, enabling the reengineering and optimization of business processes, and ultimately enhancing their core competitiveness and market responsiveness.

It is reported that the T/UNP178—2024 "Guidelines for Digital Transformation in Pharmaceutical Companies," a group standard issued by the China United Nations Procurement Promotion Association, will officially come into effect on November 23. This landmark standard will provide crucial guidance and a solid foundation for the digital transformation of the biopharmaceutical industry.

Shandong Keyuan Pharmaceutical Co., Ltd. (Stock Code: 301281.SZ), as one of the key drafting units, has contributed valuable experience and expertise to the development of this standard.

During the development of this standard, Keyuan Pharmaceutical, drawing on its own practical experience, put forward numerous valuable opinions and suggestions. These inputs were ultimately adopted and integrated into the standard, providing crucial reference and guidance for pharmaceutical companies undergoing digital transformation.

As a leading enterprise in China's niche segment of chemical APIs, Keyuan Pharmaceutical has consistently been committed to technological innovation and industrial upgrading, striving for high-quality development. Amidst the sweeping wave of digital transformation in the pharmaceutical industry, Keyuan Pharmaceutical, with its keen industry insight and strong innovative capabilities, has actively responded to national policies, implemented multiple initiatives, and accelerated the company’s digital and intelligent transformation and upgrading.

1 Building a Digital and Intelligent Factory

Layouting Next-Generation Intelligent Manufacturing

Visualization of the Intelligent Manufacturing Project for Injection-Molded Products

Keyuan Pharmaceutical is fully implementing its "Manufacturing Digitalization and Intelligentization" development strategy, accelerating the deep integration of next-generation information technology with manufacturing. This initiative aims to build a new quality of productivity, focusing on the digitalization, intelligentization, and networking of manufacturing processes, thereby driving a transformative leap from "manufacturing" to "intelligent manufacturing." Meanwhile, the company's subsidiary, Linuo Pharmaceutical, is actively constructing an intelligent manufacturing project for injectables, meticulously designed in line with the "Smart Manufacturing Level 4 Standard." This project is set to become a benchmark innovation model in areas such as digital manufacturing, smart quality inspection, and intelligent园区 management, positioning it well for consideration as a Lighthouse Factory.

After the project is completed and put into operation, it will establish a structure centered around the Jinan Data Computing Center, with distributed storage in both Shanghe and Jinan, along with secure off-site backups. At the same time, it will connect to pharmaceutical R&D databases such as Beijing Nuokanda, as well as marketing databases from Hainan GSP Company, creating a favorable scenario of multi-site interconnection and collaborative development.

In 2024, the intelligent manufacturing project for injectables was successfully selected as part of the "2024 Provincial Key Projects for Green, Low-Carbon, and High-Quality Development," highlighting Keway Pharmaceutical & Linuo Pharmaceutical's outstanding achievements in the field of digital and intelligent manufacturing.

2 Implement Lean Digital and Intelligent Operations Management

Promote quality improvement, cost reduction, and efficiency enhancement

In the context of today's rapidly evolving digital and intelligent manufacturing landscape, Lean Digitalization—representing the deep integration of lean management practices with digital technologies—empowers both approaches mutually, helping manufacturing enterprises optimize resource allocation, boost production efficiency, enhance business performance, and deliver superior customer experiences. As a result, it is increasingly gaining prominence in corporate development.

To achieve high-quality enterprise development, Keyuan Pharmaceutical has positioned lean, digital, and intelligent operational management as one of the core principles driving its corporate growth. By embracing strategies centered on leanness, standardization, automation, information technology, digitalization, intelligence, and sustainability, the company is comprehensively enhancing its production, operational, and managerial capabilities.

Under the guidance of the group's lean experts, the company established a Lean Promotion Committee and has embarked on in-depth exploration and practical implementation in building a lean production system. Actively adopting advanced tools such as digital and intelligent lean value-stream analysis, the company uses project-based improvements as a key driver to gradually establish standardized operations on the shop floor. As a result, significant enhancements have been achieved at the benchmark factory, marking solid progress toward the company's goal of improving quality, reducing costs, and boosting efficiency.

3 Wins Multiple Awards

Showcasing the Achievements of Digital and Intelligent Transformation

As a high-tech, next-generation chemical enterprise, Keyuan Pharmaceutical has always been committed to technological innovation and industrial upgrading. Actively responding to the nation’s call to promote intelligent manufacturing and digital transformation, the company is advancing in the direction of smart factories, digitized workshops, and unmanned production lines—continuously refining operations, enhancing data management, and firmly embedding the philosophy of digital and intelligent transformation into every aspect of its business.

Leveraging its outstanding innovation capabilities, remarkable achievements in digital and intelligent transformation, as well as its optimized allocation and efficient utilization of data resources, Keyuan Pharmaceutical is proudly listed on the "2024 Shandong Province Benchmark Enterprises for Intelligent Transformation in the Chemical Industry" list! Meanwhile, its subsidiary, Linuo Pharmaceutical, has been selected as a pilot enterprise for the implementation of the DCMM standard in Shandong Province for 2024!

This time, in participating in the development of the "Guidelines for Digital Transformation in Pharmaceutical Companies," Keway Pharmaceutical not only provided valuable experience and insights to the industry but also laid a solid foundation for its own sustainable growth. Moving forward, the company will continue to forge ahead boldly on the path of digital transformation, contributing even more wisdom and strength to the pharmaceutical industry's efforts toward upgrading, reshaping, and achieving high-quality development.

Showcasing fitness and style, fostering unity and igniting passion | Keyuan Pharmaceutical Holds a Table Tennis Friendship Match to Celebrate Its 20th Anniversary!

Great news! Keyuan Pharmaceutical's API, Rulacizone Hydrochloride, has successfully transitioned to Phase A!

Showcasing fitness and style, fostering unity and igniting passion | Keyuan Pharmaceutical Holds a Table Tennis Friendship Match to Celebrate Its 20th Anniversary!

Great news! Keyuan Pharmaceutical's API, Rulacizone Hydrochloride, has successfully transitioned to Phase A!